Please login to the form below

Not currently logged in
Email:
Password:

Health Canada

This page shows the latest Health Canada news and features for those working in and with pharma, biotech and healthcare.

EMA starts rapid review of Shire’s HAE antibody

EMA starts rapid review of Shire’s HAE antibody

Lanadelumab (SHP643) is also being assessed by Health Canada under a priority review application, and was submitted to the FDA last month.

Latest news

  • Not in my backyard Not in my backyard

    And then after two years of doing this from Canada, the Secretary of Health and Human Services would have the authority to permit importation from countries in the Organisation for Economic ... And if 40% of US prescriptions flow through Canada, the

  • Sanofi/Regeneron bag first approval for Actemra rival sarilumab Sanofi/Regeneron bag first approval for Actemra rival sarilumab

    Sanofi/Regeneron bag first approval for Actemra rival sarilumab. Competition to Roche’ s blockbuster RA therapy heats up as Canada is first to licence new drug. ... Health Canada has given a green light to the interleukin-6 inhibitor - under the

  • Merck buys rights to NewLink’s Ebola vaccine Merck buys rights to NewLink’s Ebola vaccine

    Merck will gain exclusive rights to rVSV-EBOV, a vaccine candidate originally developed by the Public Health Agency of Canada (PHAC) that is currently in phase I clinical trials to prevent ... Additional phase I studies are planned to take place in

  • Controversial pancreatic cancer campaign wins award Controversial pancreatic cancer campaign wins award

    Health Last campaign for the Heart and Stroke Foundation of Canada. ... Make Health Last, Heart and Stroke Foundation of Canada by Lowe Roche (Canada).

  • Trials of NewLink's Ebola vaccine 'imminent' Trials of NewLink's Ebola vaccine 'imminent'

    An experimental Ebola vaccine developed by US company NewLink Genetics will start clinical trials within the next few days, according to the World Health Organisation (WHO). ... The NewLink vaccine - based on a weakened vesicular stomatitis virus (VSV) -

More from news
Approximately 2 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Gathering pace: adaptive pathways Gathering pace: adaptive pathways

    Canada has also been developing the concept under the banner of 'progressive licensing'. ... and Finn Børlum-Kristensen from the European network for health technology assessment and Danish Health and Medicines Authority.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics